News

ESMO 2025: Novel treatment combination improves progression-free survival in metastatic, oestrogen-receptor-positive HER-2-negative breast cancer

ESMO 2025: Trial results show belzutifan shrinks rare neuroendocrine tumours and improves symptoms

ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer

ESMO 2025: Chemo combination boosts overall survival in patients with EGFR-mutant NSCLC

Study reveals how bacteria in tumours drive treatment resistance in cancer

Personalised breast cancer therapy: A new treatment approach for patients with limited tamoxifen efficacy

After cancer: Study explores caring-healing modalities for survivors

Blocking a cellular switch could prevent lung-scarring disease

ESMO 2025: Men with BRCA1 and BRCA2 gene mutations should get annual prostate cancer screening - ICR

ESMO 2025: Thymic health linked to immunotherapy response

Study links obesity-driven fatty acids to breast cancer, warns against high-fat diets like keto

From molecular pathways to potential treatments: Targeting epithelial‒mesenchymal transition in glioblastoma